SynthesisBritish journal of clinical pharmacology2026
Trends in age-sex-specific prevalence and incidence of antidepressant dispensation in the Nordic countries: a systematic review.
Synthesis in British journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of Psychotropic Use and Psychotropic Polypharmacy in a Finnish National Cohort of Persons With Intellectual Disabilities.Journal of intellectual disability research : JIDR · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Differences in antidepressant dispensation across the Nordic countries have been reported, but existing reviews are based on older data. We conducted a systematic review of population-based studies reporting prevalence and/or incidence of antidepressant dispensation in the Nordic countries. Embase, PubMed and Web of Science were searched for studies published between 1 January 2000 and 1 October 2025. Of 2728 screened records, 30 studies with data from 1994 to 2021 were included. Comparisons with Finland and Iceland were not possible due to outdated data. Antidepressant dispensation rates were higher in Sweden than in Denmark and Norway, with differences increasing over time, largely driven by rising rates in Sweden. This pattern was observed across age groups and sexes but was most pronounced among children and adolescents, particularly girls. The most recent data showed approximately 2.0-5.6 times higher prevalence and incidence of antidepressant dispensation in Sweden compared with Denmark and Norway. In 2021, the prevalence per 1000 population among 15- to 19-year-olds was 87.9 for girls and 34.7 for boys in Sweden, compared with 35.8 for girls and 14.5 for boys in Denmark and 31.6 for girls and 12.5 for boys in Norway, with a similar pattern for incidence. For adults, the prevalence pattern was similar, although incidence data were lacking. These findings underscore the need for analytical studies examining factors underlying temporal trends and cross-national differences in antidepressant dispensation, including incidence trends among adults, as well as updated population-based studies from Finland and Iceland to enable comprehensive Nordic comparisons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.